A composition comprising nanosized active pharmaceutical ingredient

Abstract

The present disclosure relates to compositions including suspensions comprising one or more nanosized active pharmaceutical ingredients (APIs) and one or more pharmaceutically acceptable oils, wherein the APIs are selected from proteins and peptides. When the APIs were nanosized and suspended in a pharmaceutically acceptable oil, their release to aqueous environment (i.e., recovery) was hindered compared to the corresponding bulk APIs suspended in the pharmaceutically acceptable oil.

Dependencies are inferred from the claim text.